The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Anti-Thyroid Drugs Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The anti-thyroid drugs market has experienced a modest expansion in its scale during recent years. Its valuation is projected to rise from $2.49 billion in 2025 to $2.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 2.0%. The historical growth of this market can be attributed to the high prevalence of hyperthyroidism, the availability of oral therapies, widespread diagnostic testing, established endocrine care, and its use in radiation protection.
The anti-thyroid drugs market size is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $2.85 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 2.9%. Several factors contribute to this projected growth, including an increase in autoimmune thyroid diseases, enhanced screening initiatives, greater availability of healthcare, advancements in thyroid regulation treatments, and a growing elderly demographic. Key developments expected during this period involve a surge in the diagnosis of thyroid disorders, an increasing adoption of thionamide-based medications, the broadening scope of outpatient thyroid care, more rigorous monitoring of hormone levels, and enhancements in the safety profiles of drugs.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Anti-Thyroid Drugs Market?
The expanding occurrence of thyroid cancer is anticipated to propel the growth of the anti-thyroid drugs market in the foreseeable future. Thyroid cancer is a medical condition affecting the thyroid gland, a structure located near the base of the throat that generates hormones regulating body temperature, heart rate, blood pressure, and weight. The heightened prevalence of this cancer is largely attributed to increased exposure to medical radiation and environmental carcinogens. Anti-thyroid drugs contribute to the early detection of thyroid cancer, which can significantly enhance treatment outcomes. For instance, in August 2023, the American Society of Clinical Oncology, a US-based organization for oncologists and surgeons, indicated that in the United States, approximately 43,720 adults (including 12,540 men and 31,180 women) received a thyroid cancer diagnosis in 2023, and an estimated 2,120 deaths (970 men and 1,150 women) from this ailment were projected for the same year. As a result, the growing prevalence of thyroid cancer is a key factor driving the anti-thyroid drugs market.
What Major Segment Divisions Exist Within The Anti-Thyroid Drugs Market?
The anti-thyroid drugs market covered in this report is segmented –
1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)
2) By Route of Administration: Oral, Intravenous, Other Route Of Administration
3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels
Subsegments:
1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil
2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution
How Are Trends Shaping The Direction Of The Anti-Thyroid Drugs Market?
Leading companies within the anti-thyroid drugs market are prioritizing product innovation, particularly with monoclonal antibodies, to enhance patient outcomes, mitigate adverse effects, and reinforce their competitive standing. Monoclonal antibodies are laboratory-engineered proteins designed to specifically target certain molecules in the body, thus facilitating more effective disease treatment. Illustratively, in March 2025, Innovent Biologics, Inc., a China-based biotechnology company, announced that China’s National Medical Products Administration (NMPA) had approved SYCUME, an anti-IGF-1R monoclonal antibody, for the treatment of thyroid eye disease (TED). SYCUME holds significance as the first drug of its kind to be approved in China and the second worldwide, presenting an effective new treatment option that considerably reduces proptosis and inflammation, while also improving patients’ quality of life. This approval was based on positive clinical trial results, which demonstrated SYCUME’s capacity to fulfill the unmet needs of TED patients, providing a safer and more accessible alternative to existing therapies.
Which Companies Are Leading Innovation In The Anti-Thyroid Drugs Market?
Major companies operating in the anti-thyroid drugs market are Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Pfizer Inc., Allergan plc, RLC LABS Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.
Read the full anti-thyroid drugs market report here:
https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report
What Are The Leading Geographic Regions In The Anti-Thyroid Drugs Market?
North America was the largest region in the anti-thyroid drugs market in 2025. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Anti-Thyroid Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp
Browse Through More Reports Similar to the Global Anti-Thyroid Drugs Market 2026, By The Business Research Company
Anti Thyroid Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report
Thyroid Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report
Anti Infective Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model